KUWAIT CITY, Jan 24: Kuwait’s Ministry of Health announced on Saturday the successful completion of the world’s first ...

Medtronic’s investment is contingent on Anteris completing a proposed $200 million public stock offering.

Researchers at the NIH and Emory School of Medicine have completed the first minimally invasive coronary artery bypass of the ...

Chris Waddell, a leader for the heart valve replacement business at Abbott, announced on social media that he is leaving the company.

Medtronic will invest $90M in Anteris Technologies for DurAVR TAVR device development, contingent on a $200M IPO.

Edwards Lifesciences Corp. faced a legal loss early this month that forced it to call off its $945 million acquisition of ...

While many people fear a cancer diagnosis above all else, clinical data reveals that symptomatic aortic stenosis, a severe ...

Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical ...

The global structural heart devices market is experiencing robust growth, driven by increasing incidences of structural heart diseases, expanded indications for transcatheter products, and a growing ...

A strategic investor has also jumped on board. The post Heart tech firm's shares surge after huge capital raise appeared ...

A federal judge has paused the merger of the only two companies developing a heart device made for high-risk patients suffering from ...

St. Luke’s Medical Center - Global City marks a significant milestone for its cardiovascular services, having successfully completed over 300 ...